Invention:
This invention combines cyanobacteria, specifically spirulina, known for its rich gamma-linolenic acid (GLA) content, with an optimal blend of fish oil or specific algae strains that are rich in eicosapentaenoic acid (EPA). The result is a product with a high protein content and unique ratios of GLA to EPA, offering a nutritional solution with potential anti-inflammatory benefits. This innovative formulation is designed not only to provide a high-protein dietary supplement but also to serve as a preventive measure against diseases and a support for overall health and well-being. The application of such combinations extends to being used as medical foods or as key ingredients in fortified foods and beverages.
Background:
This invention aims to address the inadequacy of current solutions associated with inflammation and overall health, often involving separate supplements or dietary sources for GLA and EPA. The innovative aspect lies in the formulation's ability to offer a high-protein product with precise GLA to EPA content, potentially providing a more holistic and targeted nutritional solution compared to existing options. By consolidating these essential fatty acids into a single, well-balanced product, the technology aims to enhance the effectiveness and convenience of nutritional interventions for inflammatory conditions and overall health, addressing current limitations in the fragmented approaches of existing technologies.
Applications:
- Foods
- Beverages
- Supplements
Advantages:
- Versatility
- Anti-inflammatory benefits
- Convenience
- Can be used to fortify nutritional properties in food and beverages
